Abstract
Get full access to this article
View all access options for this article.
References
1.
Zahid
MF
Murad
MH
Litzow
MR
et al. Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis . Ann Hematol . 2016 ;95 (9 ):1457 -1464 . doi: 10.1007/s00277-016-2673-3
2.
Gerber
DE
Segal
JB
Levy
MY
Kane
J
Jones
RJ
Streiff
MB
. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention . Blood . 2008 ;112 (3 ):504 -510 .
3.
National Marrow Donor Program
, A contractor for the C.W. Bill young cell transplantation program operated through the U. S. Department of Health and human services, Health resources and services administration, healthcare systems bureau. Transplant activity report covering 2012-2016. https://bloodcell.transplant.hrsa.gov/research/transplant_data/transplant_activity_report/summary-total_tx_by_year.pdf Accessed February 26, 2018.
4.
Gonsalves
A
Carrier
M
Wells
PS
Mcdiarmid
SA
Huebsch
LB
Allan
DS
. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation . J Thromb Haemostasis . 2008 ;6 (9 ):1468 -1473 .
5.
Chaturvedi
S
Neff
A
Nagler
A
Savani
U
Mohty
M
Savani
BN
. Venous thromboembolism in hematopoietic stem cell transplant recipients . Bone Marrow Transplant . 2016 ;51 (4 ):473 -478 .
6.
Kaufman
RM
Djulbegovic
B
Gernsheimer
T
et al. Platelet transfusion: a clinical practice guideline from the aabb . Ann Intern Med . 2015 ;162 (3 ):205 -213 .